Japanese Pharmacopoeia(JP) - Present and Future - Seiko Miyazaki, ... JP 16 2011. 3. 31 1764 Suppl. I 2012. 9. ... Sep 2012. Apr 2013;
Notice: This English Version of the Japanese Pharmacopoeia is published for the convenience of users unfamiliar with the Japanese language. When
PHARMACOPOEIAL DISCUSSION GROUP B-01 Amino Acid Determination, Revision 1 It is understood that sign-off covers the technical content of the draft and each
JP Skills Centre Training Schedule for 2017 DAYS JANUARY FEBRUARY MARCH APRIL MAY JUNE Sun 1 ... Microsoft Excel Basic & Inter 20 Con Ter Opr Supervisors - S4B1
European Pharmacopoeia reference substances and preparations are selected and verified by the EP ... EPA0363000 Amantadine hydrochloride 100 mg
Publication Schedule of Japanese Pharmacopoeia JP 17th Edition (JP17) Published in March 7, 2016
・Basic Principles for Preparation of JP18 (Published in October 2016)
Supplement I to JP17
・Guideline for Preparation of JP18 Draft
Published in December 1, 2017
(Published in January 2017)
Supplement Ⅱ to JP17 To be published in May 2019
JP 18th Edition (JP18) To be published in 2021 *English version is published within a year after JP publication. 1
Publication Schedule Supplement II to Japanese Pharmacopoeia 17th Edition New or revised drafts are quarterly posted on PMDA website and published in PMRJ* Japanese Pharmacopoeial Forum (JPF) for public review and comment.
Posting Date Dec. 1, 2016 Mar. 1, 2017 Jun. 1, 2017
PMRJ*: Pharmaceutical and Medical Device Regulatory Science Society of Japan
The comments, which are due in a month or three months from each posting date as specified in each forum, will be reviewed. The drafts posted between December 2016 and March 2018 will be on the Supplement II to JP17.
Sep. 1, 2017 Dec. 1, 2017 Mar. 1, 2018
Public comments are invited on the PMDA website; http://www.pmda.go.jp/english/rs-sb-std/standardsdevelopment/jp/0013.html
December 2018 - PMDA final drafts to MHLW* MHLW*: Ministry of Health, Labour and Welfare
The drafts will be reviewed at the Committee on JP under the Pharmaceutical Affairs and Food Sanitation Council and will be posted on MHLW website for public review and comment.